Article Details

RNA metabolism-focused Gotham Therapeutics launches with $54M Series A round

Retrieved on: 2018-10-09 23:54:20

Tags for this article:

Click the tags to see associated articles and topics

RNA metabolism-focused Gotham Therapeutics launches with $54M Series A round. View article details on hiswai:

Excerpt

<div>... launched in May with a $40 million Series A funding round, from a consortium that included The Column Group, <b>Atlas Venture</b> and EcoR1 Capital.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo